Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetic patients

Diabetes Care

Volumn 27, Issue 6, 2004, Pages 1299-1305

  Salles, Gil F ^a,b   Bloch, Katia V ^a   Cardoso, Claudia R L ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BRAZIL; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; POPULATION RESEARCH; PREDICTION; PROSPECTIVE STUDY; QT INTERVAL;

ADOLESCENT; ADULT; AGED; BRAZIL; CAUSE OF DEATH; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS;

EID: 2542470110     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.6.1299     Document Type: Article

References (29)

1. Kuiman MW, Welbom TA, Whittall DE: An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model. Am J Epidemiol 135:638-648, 1992
2. Wang S-L, Head J, Stevens L, Fuller JH: Excess mortality and its relation to hypertension and proteinuria in diabetic patients: the World Health Organization Multinational Study of Vascular Disease in Diabetes. Diabetes Care 19:305-312, 1996
3. Wei M, Gaskill SP, Haffner SM, Stern MP: Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality: the San Antonio Heart Study. Diabetes Care 21:1167-1172, 1998
4. De Marco R, Locatelli F, Zoppini G, Verlato G, Bonora E, Muggeo M: Cause-specific mortality in type 2 diabetes: the Verona Diabetes Study. Diabetes Care 22: 756-761, 1999
5. Chen KT, Chen CJ, Fuh MM-T, Narayan KMV: Causes of death and associated factors among patients with non-insulin-dependent diabetes mellitus in Taipei, Taiwan. Diabetes Res Clin Pract 43:101-109, 1999
6. Florkowski CM, Scott RS, Coope PA, Moir CL: Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand: a ten-year cohort study. Diabetes Res Clin Pract 53:113-120, 2001
7. Weiderpass E, Gridley G, Nyrén O, Pennello G, Landström AS, Ekbom A: Cause-specific mortality in a cohort of patients with diabetes mellitus: a population-based study in Sweden. J Clin Epidemiol 54:802-809, 2001
8. Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, Nathan DM, Manson JAE: The impact of diabetes mellitus on mortality from all-causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 161:1717-1723, 2001
9. Malerbi DA, Franco LJ: Multicenter study of the prevalence of diabetes and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. Diabetes Care 15:1509-1516, 1992
10. Fuller JH, Elford J, Goldblatt P, Adelstein AM: Diabetes mortality: new light on an underestimated public health problem. Int J Epidemiol 29:140-148, 2000
11. Gimeno SG, Ferreira SR, Franco LJ, Iunes M, Osiro K: Increase in the mortality associated with the presence of diabetes mellitus in Japanese-Brazilians. Rev Saude Publica 32:118-124, 1998
12. Cardoso C, Salles G, Deccache W: Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study. J Diabetes Complications 17:169-178, 2003
13. Cardoso CRL, Salles GF, Deccache W: QTc interval prolongation is a predictor of future strokes in patients with type 2 diabetes mellitus. Stroke 34:2187-2194, 2003
14. Cardoso C, Salles G, Bloch K, Deccache W, Siqueira-Filho AG: Clinical determinants of increased QT dispersion in patients with diabetes mellitus. Int J Cardiol 79:253-262, 2001
15. Greenland S, Finkle WD: A critical look at methods for handling missing covariates in epidemiologic regression analysis. Am J Epidemiol 142:1255-1264, 1995
16. Concato J, Feinstein AR, Holford TR: The risk of determining risk in multivariate models. Ann Intern Med 118:201-210, 1993
17. Berger B, Stenström G, Sundkvist G: Incidence, prevalence, and mortality of diabetes in a large population: a report from Skaraborg Diabetes Registry. Diabetes Care 22:773-777, 1999
18. Ford ES, DeStefano F: Risk factors for mortality from all-causes and from coronary heart disease among persons with diabetes. Am J Epidemiol 133:1220-1230, 1991
19. Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H: Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 44:1303-1309, 1995
20. Christensen PK, Gall MA, Major-Pedersen A, Sato A, Rossing P, Breum L, Pietersen A, Kastrup J, Parving HH: QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes. Scand J Clin Lab Invest 60:323-332, 2000
21. Ostgren CJ, Lindblad U, Melander A, Rastan L: Survival in patients with type 2 diabetes in a Swedish community: Skaraborg Hypertension and Diabetes Project. Diabetes Care 25:1297-1302, 2002
22. Sawicki PT, Kiwitt S, Bender R, Berger M: The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. J Intern Med 243:49-56, 1998
23. Laakso M, Lehto S, Penttilä I, Pyörälä K: Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88:1421-1430, 1993
24. Knutsen R, Knutsen SF, Curb JD, Reed DM, Kautz JA, Yano K: The predictive value of resting electrocardiograms for 12-year incidence of coronary heart disease in the Honolulu Heart Program. J Clin Epidemiol 41:293-302, 1988
25. Curb JD, Rodriguez BL, Burchfiel CM, Abbott RD, Chiu D, Yano K: Sudden death, impaired glucose tolerance and diabetes in Japanese American men. Circulation 91:2591-2595, 1995
26. Whitsel EA, Boyko EJ, Siscovick DS: Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes. Diabetes Care 23:241-247, 2000
27. Festa A, D'Agostino R Jr, Rautaharju P, Mykkänen L, Haffner SM: Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol 86:1117-1122, 2000
28. Dekker JM, Feskens EJM, Schouten EG, Klootwijk P, Pool J, Kromhout D: QTc duration is associated with levels of insulin and glucose tolerance: the Zutphen Elderly Study. Diabetes 45:376-380, 1996
29. Mooradian AD: Cardiovascular disease in type 2 diabetes mellitus: current management guidelines. Arch Intern Med 163:33-40, 2003